12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Tuesday's intraday session, several healthcare stocks experienced significant price movements. Hoth Therapeutics, Synlogic, Castle Biosciences, Tenon Medical, eFFECTOR Therapeutics, and AlloVir were among the gainers, while HTG Molecular Diagnostics, NovoCure, VistaGen Therapeutics, NRX Pharmaceuticals, TransCode Therapeutics, and Myomo were among the losers.
June 06, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AlloVir shares increased by 18.16% to $5.27, with trading volume reaching 120.8% of its average full-day volume.
AlloVir's stock price increase and above-average trading volume suggest positive investor sentiment, which could result in short-term gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Castle Biosciences shares moved upwards by 23.62% to $14.41, with trading volume reaching 1102.0% of its average full-day volume.
Castle Biosciences' significant price increase and extremely high trading volume indicate strong investor interest, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
eFFECTOR Therapeutics shares rose 19.8% to $1.21, with trading volume reaching 173.1% of its average full-day volume.
eFFECTOR Therapeutics' stock price increase and above-average trading volume suggest positive investor sentiment, which could result in short-term gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Hoth Therapeutics shares surged 66.5% to $3.13 during Tuesday's session, with trading volume reaching 38144.1% of its average full-day volume.
Hoth Therapeutics' significant price increase and extremely high trading volume indicate strong investor interest, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Synlogic's stock rose 25.39% to $0.61, with trading volume reaching 135.4% of its average full-day volume.
Synlogic's stock price increase and above-average trading volume suggest positive investor sentiment, which could result in short-term gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Tenon Medical's stock moved upwards by 22.54% to $1.25, with trading volume reaching 226.2% of its average full-day volume.
Tenon Medical's stock price increase and above-average trading volume suggest positive investor sentiment, which could result in short-term gains.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
HTG Molecular Diagnostics stock fell 45.8% to $0.91, with trading volume reaching 394.2% of its average full-day volume.
HTG Molecular Diagnostics' significant price decrease and high trading volume indicate negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Myomo shares decreased by 16.82% to $0.47, with trading volume reaching 90.0% of its average full-day volume.
Myomo's stock price decrease and near-average trading volume suggest negative investor sentiment, which could result in short-term losses.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
NRX Pharmaceuticals stock fell 23.08% to $0.5, with trading volume reaching 590.0% of its average full-day volume.
NRX Pharmaceuticals' significant price decrease and high trading volume indicate negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
NovoCure stock decreased by 35.53% to $53.2, with trading volume reaching 840.5% of its average full-day volume.
NovoCure's significant price decrease and extremely high trading volume indicate negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 95
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
TransCode Therapeutics shares declined by 17.25% to $3.31, with trading volume reaching 220.8% of its average full-day volume.
TransCode Therapeutics' stock price decrease and above-average trading volume suggest negative investor sentiment, which could result in short-term losses.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
VistaGen Therapeutics stock declined by 23.96% to $0.1, with trading volume reaching 236.6% of its average full-day volume.
VistaGen Therapeutics' stock price decrease and above-average trading volume suggest negative investor sentiment, which could result in short-term losses.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100